Cargando…

Long-Term Exposure to PFE-360 in the AAV-α-Synuclein Rat Model: Findings and Implications

Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with impaired motor function and several non-motor symptoms, with no available disease modifying treatment. Intracellular accumulation of pathological α-synuclein inclusions is a hallmark of idiopathic PD, whereas, domin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andersen, Michael Aagaard, Sotty, Florence, Jensen, Poul Henning, Badolo, Lassina, Jeggo, Ross, Smith, Garrick Paul, Christensen, Kenneth Vielsted
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Neuroscience 2019
Materias:	New Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978918/ https://www.ncbi.nlm.nih.gov/pubmed/31685675 http://dx.doi.org/10.1523/ENEURO.0453-18.2019

Ejemplares similares

Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson’s disease using electrophysiological measurements of visual processing
por: Østergaard, Freja Gam, et al.
Publicado: (2020)

Primary failure of eruption (PFE): a systematic review
por: Hanisch, Marcel, et al.
Publicado: (2018)

Swimming exercise reduces native ⍺-synuclein protein species in a transgenic C. elegans model of Parkinson’s disease.
por: Schmidt, Minna Y., et al.
Publicado: (2021)

The Esterase PfeE, the Achilles’ Heel in the Battle for Iron between Pseudomonas aeruginosa and Escherichia coli
por: Gasser, Véronique, et al.
Publicado: (2021)

Validating clinical characteristics of primary failure of eruption (PFE) associated with PTH1R variants
por: Grippaudo, Cristina, et al.
Publicado: (2021)

Sarkosyl differentially solubilizes patient-derived alpha-synuclein fibril strains
por: Gram, Hjalte, et al.
Publicado: (2023)

Stabilization of α-synuclein oligomers using formaldehyde
por: Ruesink, Harm, et al.
Publicado: (2019)

No Detectable Effect on Visual Responses Using Functional MRI in a Rodent Model of α-Synuclein Expression
por: Østergaard, Freja Gam, et al.
Publicado: (2021)

Gene Transfer in Rodent Nervous Tissue Following Hindlimb Intramuscular Delivery of Recombinant Adeno-Associated Virus Serotypes AAV2/6, AAV2/8, and AAV2/9
por: Jan, Asad, et al.
Publicado: (2019)

Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein
por: Chen, Yun-Hsiang, et al.
Publicado: (2021)

Polo-like kinase 2 inhibition reduces serine-129 phosphorylation of physiological nuclear alpha-synuclein but not of the aggregated alpha-synuclein
por: Elfarrash, Sara, et al.
Publicado: (2021)

Identification of Synaptosomal Proteins Binding to Monomeric and Oligomeric α-Synuclein
por: Betzer, Cristine, et al.
Publicado: (2015)

Hsc70 Ameliorates the Vesicle Recycling Defects Caused by Excess α-Synuclein at Synapses
por: Banks, Susan M. L., et al.
Publicado: (2020)

Hsc70 rescues the synaptic vesicle trafficking defects caused by α-synuclein dimers
por: Brady, Emily B., et al.
Publicado: (2023)

The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
por: Jan, Asad, et al.
Publicado: (2021)

Characterisation of functional deficits induced by AAV overexpression of alpha-synuclein in rats
por: Gubinelli, F., et al.
Publicado: (2022)

Mutation of Tyrosine Sites in the Human Alpha-Synuclein Gene Induces Neurotoxicity in Transgenic Mice with Soluble Alpha-Synuclein Oligomer Formation
por: Lassen, Louise Berkhoudt, et al.
Publicado: (2022)

ELISA method to detect α-synuclein oligomers in cell and animal models
por: Lassen, Louise Berkhoudt, et al.
Publicado: (2018)

Synthesis of hybrid hydrophobic composite air filtration membranes for antibacterial activity and chemical detoxification with high particulate filtration efficiency (PFE)
por: Vanangamudi, Anbharasi, et al.
Publicado: (2015)

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?
por: Lübbers, Katharina, et al.
Publicado: (2021)

The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
por: Kelly, Rachel, et al.
Publicado: (2021)

Target-Mediated Brain Tissue Binding for Small Molecule Inhibitors of Heat Shock Protein 90
por: Badolo, Lassina, et al.
Publicado: (2020)

Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain
por: Delenclos, Marion, et al.
Publicado: (2017)

A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones
por: Liu, Wei, et al.
Publicado: (2021)

Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2
por: Laleu, Benoît, et al.
Publicado: (2022)

α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin
por: Lieberman, Ori J., et al.
Publicado: (2017)

Overexpression of Parkinson’s Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
por: Xiong, Yulan, et al.
Publicado: (2017)

Structural and functional characterization of two alpha-synuclein strains
por: Bousset, Luc, et al.
Publicado: (2013)

Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson’s Disease
por: Brembati, Viviana, et al.
Publicado: (2023)

Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
por: Gregersen, Emil, et al.
Publicado: (2021)

Electrostatic self-assembly of pFe(3)O(4) nanoparticles on graphene oxide: A co-dispersed nanosystem reinforces PLLA scaffolds
por: Yang, Wenjing, et al.
Publicado: (2020)

Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)
por: Chalermphanchai, Nipon, et al.
Publicado: (2022)

Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family
por: Kojovic, Maja, et al.
Publicado: (2012)

Endogenous Oligodendroglial Alpha-Synuclein and TPPP/p25α Orchestrate Alpha-Synuclein Pathology in Experimental Multiple System Atrophy Models
por: Mavroeidi, Panagiota, et al.
Publicado: (2019)

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
por: Just, Mie Kristine, et al.
Publicado: (2022)

Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy
por: Sargent, Dorian, et al.
Publicado: (2018)

Regulatory Elements Inserted into AAVs Confer Preferential Activity in Cortical Interneurons
por: Rubin, Anna N., et al.
Publicado: (2020)

Selectively Imaging Cranial Sensory Ganglion Neurons Using AAV-PHP.S
por: Asencor, Andoni I., et al.
Publicado: (2022)

Salivary α‐Synuclein RT‐QuIC Correlates with Disease Severity in de novo Parkinson's Disease
por: Vivacqua, Giorgio, et al.
Publicado: (2022)

Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein
por: Reimer, Lasse, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sb5q5ce1uped8vpu0d9gmfmkgv